7199 results for "({!join from=dataset_studies to=id v=$q1}) OR ("transcriptome" OR "RNA-seq" OR "rna sequencing" OR "rna-sequencing")"

in 20.99 milliseconds.

• DAC: Brain transcriptome of hereditary cerebral haemorrhage with amyloidosis–Dutch type (HCHWA-D)

  Dac EGAC00001000771

• Transcriptome profiling by array

  Expression profiling by Nanostring cancer immune

  Dataset EGAD00010001274

• Spatial Transcriptomic

  Spatial Transcriptomic

  Dataset EGAD50000000136

• Whole-genome and transcriptome sequencing of blastic plasmacytoid dendritic cell neoplasm

  Study EGAS00001003660

• Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia

  Study EGAS00001004994

• Single-cell sequencing of adipose-derived mesenchymal stromal cells and dermal fibroblasts

  Study EGAS00001006954

• Follicular Lymphoma Whole Genome and Transcriptome Sequencing

  Study EGAS00001006646

• healthy reference patients

  Healthy reference samples

  Dataset EGAD00001001081

• Neoadjuvant chemotherapy alters the genomic landscape and immune microenvironment of breast cancers

  To characterize the effects of neoadjuvant chemotherapy (NAC) on the genome, transcriptome and tumor infiltrating leukocytes (TILs), we have conducted whole exome and whole transcriptome sequencing of a comprehensive, longitudinal breast cancer cohort consisting of 146 cases and 281 paired tumor samples. In total, 52 (38%) patients achieved pathologic complete response (pCR) while 85 patients (62%) had residual disease with standard chemotherapy regimen. Tumor biopsies were collected for each patient at three time points – pre-treatment, three weeks after the first cycle of anthracycline and cyclophosphamide (AC) and at the time of surgery after 3 more cycles of AC followed by 4 cycles of taxane or taxane plus Herceptin in case of HER2+ subtype.

  Study EGAS00001003354

• CD3 bispecific antibody-induced cytokine release is dispensable for cytotoxic T cell activity

  Study EGAS00001003734